Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.
Identifieur interne : 001617 ( PubMed/Curation ); précédent : 001616; suivant : 001618Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.
Auteurs : Michelle Chonwerawong ; Patrick Avé [France] ; Michel Huerre [France] ; Richard L. FerreroSource :
- Gut pathogens [ 1757-4749 ] ; 2016.
Abstract
Mouse infection studies have shown that interferon-γ (IFN-γ), a T helper 1 (Th1) cytokine, is required for the development of severe pathology induced by chronic Helicobacter infection. This finding is largely based on studies performed using mice that have polarised Th1 responses i.e. C57BL/6 animals. The current work aims to investigate the role of IFN-γ in Helicobacter-induced inflammation in BALB/c mice which have Th2-polarised immune responses.
DOI: 10.1186/s13099-016-0142-0
PubMed: 27895717
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001639
Links to Exploration step
pubmed:27895717Curation
No country items
Michelle Chonwerawong<affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia.</nlm:affiliation>
<wicri:noCountry code="subField">VIC 3123 Australia</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia ; Department of Microbiology, Monash University, Clayton, VIC Australia.</nlm:affiliation>
<wicri:noCountry code="subField">VIC Australia</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.</title>
<author><name sortKey="Chonwerawong, Michelle" sort="Chonwerawong, Michelle" uniqKey="Chonwerawong M" first="Michelle" last="Chonwerawong">Michelle Chonwerawong</name>
<affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia.</nlm:affiliation>
<wicri:noCountry code="subField">VIC 3123 Australia</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ave, Patrick" sort="Ave, Patrick" uniqKey="Ave P" first="Patrick" last="Avé">Patrick Avé</name>
<affiliation wicri:level="1"><nlm:affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Huerre, Michel" sort="Huerre, Michel" uniqKey="Huerre M" first="Michel" last="Huerre">Michel Huerre</name>
<affiliation wicri:level="1"><nlm:affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ferrero, Richard L" sort="Ferrero, Richard L" uniqKey="Ferrero R" first="Richard L" last="Ferrero">Richard L. Ferrero</name>
<affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia ; Department of Microbiology, Monash University, Clayton, VIC Australia.</nlm:affiliation>
<wicri:noCountry code="subField">VIC Australia</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27895717</idno>
<idno type="pmid">27895717</idno>
<idno type="doi">10.1186/s13099-016-0142-0</idno>
<idno type="wicri:Area/PubMed/Corpus">001639</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001639</idno>
<idno type="wicri:Area/PubMed/Curation">001617</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001617</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.</title>
<author><name sortKey="Chonwerawong, Michelle" sort="Chonwerawong, Michelle" uniqKey="Chonwerawong M" first="Michelle" last="Chonwerawong">Michelle Chonwerawong</name>
<affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia.</nlm:affiliation>
<wicri:noCountry code="subField">VIC 3123 Australia</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ave, Patrick" sort="Ave, Patrick" uniqKey="Ave P" first="Patrick" last="Avé">Patrick Avé</name>
<affiliation wicri:level="1"><nlm:affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Huerre, Michel" sort="Huerre, Michel" uniqKey="Huerre M" first="Michel" last="Huerre">Michel Huerre</name>
<affiliation wicri:level="1"><nlm:affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ferrero, Richard L" sort="Ferrero, Richard L" uniqKey="Ferrero R" first="Richard L" last="Ferrero">Richard L. Ferrero</name>
<affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia ; Department of Microbiology, Monash University, Clayton, VIC Australia.</nlm:affiliation>
<wicri:noCountry code="subField">VIC Australia</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">Gut pathogens</title>
<idno type="ISSN">1757-4749</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Mouse infection studies have shown that interferon-γ (IFN-γ), a T helper 1 (Th1) cytokine, is required for the development of severe pathology induced by chronic Helicobacter infection. This finding is largely based on studies performed using mice that have polarised Th1 responses i.e. C57BL/6 animals. The current work aims to investigate the role of IFN-γ in Helicobacter-induced inflammation in BALB/c mice which have Th2-polarised immune responses.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27895717</PMID>
<DateCreated><Year>2016</Year>
<Month>11</Month>
<Day>29</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>08</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1757-4749</ISSN>
<JournalIssue CitedMedium="Print"><Volume>8</Volume>
<PubDate><Year>2016</Year>
</PubDate>
</JournalIssue>
<Title>Gut pathogens</Title>
<ISOAbbreviation>Gut Pathog</ISOAbbreviation>
</Journal>
<ArticleTitle>Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.</ArticleTitle>
<Pagination><MedlinePgn>61</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mouse infection studies have shown that interferon-γ (IFN-γ), a T helper 1 (Th1) cytokine, is required for the development of severe pathology induced by chronic Helicobacter infection. This finding is largely based on studies performed using mice that have polarised Th1 responses i.e. C57BL/6 animals. The current work aims to investigate the role of IFN-γ in Helicobacter-induced inflammation in BALB/c mice which have Th2-polarised immune responses.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At 7 months post-infection with Helicobacter felis, IFN-γ deficiency in BALB/c mice had no significant effect on H. felis colonisation levels in the gastric mucosa, nor on humoral responses, or gastritis severity. Ifng(-/-) animals with chronic H. felis infection did, however, develop significantly fewer lymphoid follicle lesions, as well as increased IL-4 splenocyte responses, when compared with infected Ifng(+/+) mice (P = 0.015 and P = 0.0004, respectively).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The work shows that in mice on a BALB/c background, IFN-γ is not required for bacterial clearance, antibody responses, nor gastric inflammation. Conversely, IFN-γ appears to play a role in the development of gastric lymphoid follicles, which are precursor lesions to mucosa-associated lymphoid tissue (MALT) lymphoma. This study highlights the importance of mouse host background on the susceptibility to Helicobacter-induced pathologies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chonwerawong</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Avé</LastName>
<ForeName>Patrick</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Huerre</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ferrero</LastName>
<ForeName>Richard L</ForeName>
<Initials>RL</Initials>
<Identifier Source="ORCID">0000-0001-6817-6211</Identifier>
<AffiliationInfo><Affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia ; Department of Microbiology, Monash University, Clayton, VIC Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>11</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Gut Pathog</MedlineTA>
<NlmUniqueID>101474263</NlmUniqueID>
<ISSNLinking>1757-4749</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>APMIS. 2015 Jul;123(7):571-9</RefSource>
<PMID Version="1">26010562</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1995 Jul;147(1):217-22</RefSource>
<PMID Version="1">7604881</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1988 Feb 15;140(4):1022-7</RefSource>
<PMID Version="1">3125247</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2001 Jun 15;166(12):7456-61</RefSource>
<PMID Version="1">11390498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 1987 May 22;236(4804):944-7</RefSource>
<PMID Version="1">3107127</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2010 Jun;24(6):1186-96</RefSource>
<PMID Version="1">20428202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2007 Aug;133(2):659-72</RefSource>
<PMID Version="1">17681184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biomed Biotechnol. 2010;2010:104918</RefSource>
<PMID Version="1">20617132</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1999 Aug 1;163(3):1490-7</RefSource>
<PMID Version="1">10415051</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2008 Feb;76(2):551-61</RefSource>
<PMID Version="1">18070899</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1998 Oct;115(4):891-7</RefSource>
<PMID Version="1">9753492</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gut. 1999 Sep;45(3):335-40</RefSource>
<PMID Version="1">10446099</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2005 Jun;128(7):1937-52</RefSource>
<PMID Version="1">15940628</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2004 Nov;5(11):1166-74</RefSource>
<PMID Version="1">15489856</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1997 Apr;112(4):1386-97</RefSource>
<PMID Version="1">9098027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cancer Prev. 2014 Sep;19(3):224-30</RefSource>
<PMID Version="1">25337592</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1996 Jun 15;156(12):4729-38</RefSource>
<PMID Version="1">8648119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gut. 2004 Aug;53(8):1082-9</RefSource>
<PMID Version="1">15247172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2005 Sep;167(3):797-812</RefSource>
<PMID Version="1">16127158</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2007 Apr;75(4):1738-44</RefSource>
<PMID Version="1">17220306</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1999 Dec;155(6):2019-27</RefSource>
<PMID Version="1">10595932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gut. 1996 Nov;39(5):639-48</RefSource>
<PMID Version="1">9026476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vet Pathol. 2012 Jan;49(1):32-43</RefSource>
<PMID Version="1">22135019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2004 Aug;203(4):896-903</RefSource>
<PMID Version="1">15258991</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2003 Jun;71(6):3628-33</RefSource>
<PMID Version="1">12761151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Scand J Gastroenterol. 2001 Nov;36(11):1198-203</RefSource>
<PMID Version="1">11686221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2009 Jun 1;182(11):7085-101</RefSource>
<PMID Version="1">19454706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2000 Jul;191(3):333-40</RefSource>
<PMID Version="1">10878557</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 1999 Jun;67(6):3040-6</RefSource>
<PMID Version="1">10338517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2010 May 1;184(9):5121-9</RefSource>
<PMID Version="1">20351183</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Microbes Infect. 2000 May;2(6):593-7</RefSource>
<PMID Version="1">10884609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2007 Jun 7;13(21):2923-31</RefSource>
<PMID Version="1">17589941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mucosal Immunol. 2015 Mar;8(2):279-95</RefSource>
<PMID Version="1">25073677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 2005 Dec;142(3):498-504</RefSource>
<PMID Version="1">16297162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1997 Jul;113(1):185-94</RefSource>
<PMID Version="1">9207277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2013 Mar;81(3):740-52</RefSource>
<PMID Version="1">23264048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 1993 Mar 19;259(5102):1742-5</RefSource>
<PMID Version="1">8456301</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int Immunol. 1993 Aug;5(8):885-91</RefSource>
<PMID Version="1">8398983</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Immunol Today. 1997 Feb;18(2):61-4</RefSource>
<PMID Version="1">9057354</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Pathol. 1997 Nov;50(11):957-9</RefSource>
<PMID Version="1">9462249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2011 Jun 1;186(11):6165-72</RefSource>
<PMID Version="1">21518972</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1997 May;150(5):1583-93</RefSource>
<PMID Version="1">9137085</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pathol. 1996 Feb;178(2):122-7</RefSource>
<PMID Version="1">8683376</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1997 Dec;113(6):1848-57</RefSource>
<PMID Version="1">9394724</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1998 May;152(5):1377-86</RefSource>
<PMID Version="1">9588906</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1999 Nov;117(5):1105-12</RefSource>
<PMID Version="1">10535873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2000 Jul 15;165(2):1022-9</RefSource>
<PMID Version="1">10878379</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gut. 1995 Mar;36(3):341-5</RefSource>
<PMID Version="1">7698689</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1998 Mar;114(3):482-92</RefSource>
<PMID Version="1">9496938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>APMIS. 2003 Apr;111(4):514-22</RefSource>
<PMID Version="1">12780527</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2004 Aug;72(8):4668-79</RefSource>
<PMID Version="1">15271928</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2001 Mar;69(3):1714-21</RefSource>
<PMID Version="1">11179348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 1999 Jan;67(1):279-85</RefSource>
<PMID Version="1">9864227</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2001 Nov;69(11):6749-54</RefSource>
<PMID Version="1">11598047</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1998 Jun;152(6):1625-32</RefSource>
<PMID Version="1">9626066</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BALB/c</Keyword>
<Keyword MajorTopicYN="N">Gastric inflammation</Keyword>
<Keyword MajorTopicYN="N">Helicobacter</Keyword>
<Keyword MajorTopicYN="N">Interferon-gamma</Keyword>
<Keyword MajorTopicYN="N">Lymphoid follicle</Keyword>
<Keyword MajorTopicYN="N">MALT lymphoma</Keyword>
<Keyword MajorTopicYN="N">Mucosa-associated lymphoid tissue</Keyword>
<Keyword MajorTopicYN="N">T helper response</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>10</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>11</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>11</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27895717</ArticleId>
<ArticleId IdType="doi">10.1186/s13099-016-0142-0</ArticleId>
<ArticleId IdType="pii">142</ArticleId>
<ArticleId IdType="pmc">PMC5117576</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001617 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001617 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:27895717 |texte= Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:27895717" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |